Cargando…
Pharmaceutical and Safety Profile Evaluation of Novel Selenocompounds with Noteworthy Anticancer Activity
Prior studies have reported the potent and selective cytotoxic, pro-apoptotic, and chemopreventive activities of a cyclic selenoanhydride and of a series of selenoesters. Some of these selenium derivatives demonstrated multidrug resistance (MDR)-reversing activity in different resistant cancer cell...
Autores principales: | Marć, Małgorzata Anna, Domínguez-Álvarez, Enrique, Latacz, Gniewomir, Doroz-Płonka, Agata, Sanmartín, Carmen, Spengler, Gabriella, Handzlik, Jadwiga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875489/ https://www.ncbi.nlm.nih.gov/pubmed/35214099 http://dx.doi.org/10.3390/pharmaceutics14020367 |
Ejemplares similares
-
Selenocompounds as Novel Antibacterial Agents and Bacterial Efflux Pump Inhibitors
por: Mosolygó, Tímea, et al.
Publicado: (2019) -
Novel Library of Selenocompounds as Kinase Modulators
por: Plano, Daniel, et al.
Publicado: (2011) -
Are the Hydantoin-1,3,5-triazine 5-HT(6)R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro
por: Lubelska, Annamaria, et al.
Publicado: (2019) -
Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance
por: Kaczor, Aneta, et al.
Publicado: (2020) -
Molecular Insights into an Antibiotic Enhancer Action of New Morpholine-Containing 5-Arylideneimidazolones in the Fight against MDR Bacteria
por: Kaczor, Aneta, et al.
Publicado: (2021)